low-dose tamoxifen for invasive breast cancer

Release time ：Dec-18,2024

Low-dose tamoxifen may serve as a treatment option for invasive breast cancer. This medication works by blocking estrogen's effects, thereby inhibiting tumor cell growth, and is particularly effective in patients with hormone receptor-positive breast cancer.

Typically, the use of low-dose tamoxifen begins with milder side effects such as hot flashes and vaginal dryness. With an increase in dosage, more severe side effects may emerge, including the risk of endometrial hyperplasia and a heightened risk of thrombosis. Consequently, physicians adjust the tamoxifen dosage based on the patient's condition and tolerance to optimize therapeutic outcomes while minimizing adverse effects.

During treatment with low-dose tamoxifen, patients should adhere to their physician's instructions, including regular blood tests and other necessary monitoring to ensure the medication's safety and efficacy. Additionally, patients are advised to make lifestyle adjustments, such as maintaining a healthy diet, engaging in moderate exercise, and abstaining from smoking and alcohol consumption, all of which contribute to enhancing treatment outcomes and overall quality of life.